Skip to main content
Song Li, MD, Cardiology, Dallas, TX

Song Li MD

Heart Failure & Transplantation


Director of Cardiogenic Shock

Join to View Full Profile
  • 11970 N Central ExpySte 550Dallas, TX 75243

  • Phone+1 972-940-9520

  • Fax+1 972-940-9535

Dr. Li is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Washington School of Medicine
    University of Washington School of MedicineFellowship, Advanced Heart Failure and Transplant Cardiology, 2018 - 2019
  • University of Washington
    University of WashingtonFellowship, Cardiovascular Disease, 2015 - 2018
  • Emory University School of Medicine
    Emory University School of MedicineChief Residency, Internal Medicine, 2014 - 2015
  • Emory University School of Medicine
    Emory University School of MedicineResidency, Internal Medicine, 2011 - 2014
  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 2011
  • Grinnell College
    Grinnell CollegeBA, Biochemistry, 2003 - 2007

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2023 - 2026
  • WA State Medical License
    WA State Medical License 2015 - 2025
  • ID State Medical License
    ID State Medical License 2022 - 2024
  • GA State Medical License
    GA State Medical License 2014 - 2015
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Advanced Heart Failure and Transplant Cardiology
    American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Phi Beta Kappa Honor Society 2007
  • Mortar Board Honor Society 2006

Publications & Presentations

PubMed

Journal Articles

  • Heterosubtypic Influenza Protection Elicited by Double-Layered Polypeptide Nanoparticles in Mice  
    Song Li, MD, Proceedings of the National Academy of Sciences

Books/Book Chapters

Press Mentions

  • Science News | Research: Innovative Cancer Chemoimmunotherapy Provided by Novel Nanoparticles
    Science News | Research: Innovative Cancer Chemoimmunotherapy Provided by Novel NanoparticlesNovember 25th, 2022
  • Study Sifts Potential Factors of Device-Implant Complication
    Study Sifts Potential Factors of Device-Implant ComplicationOctober 31st, 2022

Grant Support

  • Targeting iRhom to Improve Colon Cancer ImmunochemotherapyUNIVERSITY OF PITTSBURGH AT PITTSBURGH2025–2029
  • Nanoparticles-mediated combination therapy for breast cancerUNIVERSITY OF PITTSBURGH AT PITTSBURGH2023–2028
  • Combination Therapy for Pancreatic CancerUNIVERSITY OF PITTSBURGH AT PITTSBURGH2023–2028
  • Mechanopriming for cell engineeringUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
  • Mechanopriming for cell engineeringUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
  • Mechanopriming for cell engineeringUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
  • Mechanopriming for cell engineeringUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
  • Mechanopriming for cell engineeringUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
  • Mechanopriming for cell engineeringUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
  • Mechanopriming for cell engineeringUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
  • Multimodal wireless electrical stimulation for tissue regenerationUNIVERSITY OF CALIFORNIA LOS ANGELES2022–2027
  • Regulation of cell reprogramming by matrix stiffnessUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
  • Regulation of cell reprogramming by matrix stiffnessUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
  • Regulation of cell reprogramming by matrix stiffnessUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
  • Regulation of cell reprogramming by matrix stiffnessUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
  • Regulation of cell reprogramming by matrix stiffnessUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
  • Regulation of cell reprogramming by matrix stiffnessUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
  • Regulation of cell reprogramming by matrix stiffnessUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
  • Study of Interleukin 33 as a new immunotherapy of lung cancerHACKENSACK UNIVERSITY MEDICAL CENTER2019–2025
  • Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer ImmunotherapyUNIVERSITY OF CALIFORNIA LOS ANGELES2019–2024

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: